The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute

Researcher Isabelle Plo and Dr William Vainchenker, a haematologist and researcher at Gustave Roussy, have co-authored a landmark review on myeloproliferative neoplasms (MPNs), published in the New England Journal of Medicine on 19 August. The article summarises major advances in understanding these blood cancers and highlights therapeutic...

« Great advances in oncology » - Episode 4/4. In 1952, Dr Odile Schweisguth established Europe’s first paediatric oncology department at Gustave Roussy, at a time when the specialty was largely overlooked. Until her retirement in 1978, she fought to ensure that childhood tumours received dedicated and appropriate care, both in France and...

Last quarter also brought several other noteworthy developments. Researchers reported that delivering part of chemotherapy more precisely after surgery can help treat liver metastases, that antibody drug conjugates (ADCs) provide an additional treatment option in certain metastatic breast cancers, that nuclear medicine is showing encouraging...

« Great advances in oncology » – Episode 3/4. Now considered indispensable in oncology, molecular profiling of tumours is one of the cornerstones of precision medicine. As early as 2011, three physician-researchers at Gustave Roussy outlined its key principles in an article published in the Journal of Clinical Oncology, with a clear ambition: to...